logo

FDA Calendar

Share
Company Name Trevena, Inc.
Drug Name IV Oliceridine (Resubmitted NDA)
Event Name FDA decision on IV Oliceridine for the management of moderate-to-severe acute pain
Event Date 08/07/2020
Outcome Date
Outcome
Drug Status FDA had issued a Complete Response Letter for IV Oliceridine in November 2018
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar